{
    "address": "Lefflersgatan 5",
    "city": "Uppsala",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W2R205106",
    "description": "Corline Biomedical AB engages in the research, development, and commercialization of heparin based solutions. The company is headquartered in Uppsala, Uppsala and currently employs 8 full-time employees. The company went IPO on 2015-06-03. The company develops, manufactures and markets heparin-based solutions to improve kidney transplantation, cell therapies and applications in regenerative medicine.",
    "employeeTotal": "8.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Pharmaceuticals",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Pharmaceuticals",
    "gsector": "Health Care",
    "gsubind": "Pharmaceuticals",
    "ipo": "2015-06-03",
    "isin": "SE0006887451",
    "logo": "",
    "marketCapitalization": 294.4242,
    "naics": "Pharmaceutical and Medicine Manufacturing",
    "naicsNationalIndustry": "Pharmaceutical Preparation Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Chemical Manufacturing",
    "name": "Corline Biomedical AB",
    "phone": "461871346946.0",
    "sedol": "BYR8C86",
    "shareOutstanding": 16.674918,
    "state": "UPPSALA",
    "ticker": "CLBIO.ST",
    "weburl": "http://www.corline.se/"
}